Skip to content
RDL
Network
Ekosistem
Uygulama değiştir
EN
Hakkımızda
SSS
Giriş yap
Başla
Systemic administration of bevacizumab increases the risk of cardiovascular events in patients with metastatic cancer — Christodoulos Stefanadis (2011) | RDL Network
Back
Cite
Save
Save for later
Share
Home
Publications
Systemic administration of bevacizumab increases the risk of cardiovascular events in patients with metastatic cancer
Shared by
Meletios A Dimopoulos
Systemic administration of bevacizumab increases the risk of cardiovascular events in patients with metastatic cancer
Letter
2011
en
Authors
+8 more
CS
Christodoulos Stefanadis
AS
Andreas Synetos
DT
Dimitris Tousoulis
Discussion
(0)
Sign in
to like and join the discussion.
No comments yet. Be the first to comment.
Related publications
Article
2016
Bevacizumab increases the incidence of cardiovascular events in patients with metastatic breast or colorectal cancer
Ioannis Kapelakis
,
Konstantinos Toutouzas
,
Maria Drakopoulou
,
Archontoula Michelongona
,
Flora Zagouri
,
Aristotle Mpamias
,
Paraskevi Pliatsika
,
Meletios A Dimopoulos
,
Christodoulos Stefanadis
,
Dimitrios Tousoulis
Article
2012
THE ADDITION OF BEVACIZUMAB IN THE TREATMENT OF PATIENTS WITH METASTASTIC CANCER, INCREASES THE INCIDENCE OF CARDIOVASCULAR EVENTS: A PROSPECTIVE STUDY
Archontoula Michelongona
,
Konstantinos Toutouzas
,
Andreas Synetos
,
Flora Zagouri
,
Aristotle Bamias
,
Meletios A Dimopoulos
,
Stella Kyvelou
,
Ioannis Kapelakis
,
Dimitris Tousoulis
,
Christodoulos Stefanadis
Article
2011
Paclitaxel and bevacizumab as first line combined treatment in patients with metastatic breast cancer
George Fountzilas
,
D. Pectasides
,
Ioannis Efstratiou
,
Dimitra Repana
,
Evangelia Razis
,
Kostas Papazisis
,
Meletios A Dimopoulos
,
Christos N. Papandreou
,
C. Papadimitriou
,
Despina Televantou
,
Pavlos Papakostas
,
Gerasimos Aravantinos
,
George Pentheroudakis
,
Dimitrios Bafaloukos
,
Kalliopi Petraki
,
Constantina Christodoulou
,
Αngelos Koutras
,
Dimosthenis Miliaras
,
H. Kourea
,
Mattheos Bobos
,
Vasiliki Kotoula-Dimitriadou
,
Eleni Timotheadou
Article
2014
Association of VEGF-A Splice Variant mRNA Expression With Outcome in Bevacizumab-Treated Patients With Metastatic Breast Cancer
George Pentheroudakis
,
Vassiliki Kotoula
,
George Kouvatseas
,
Elpida Charalambous
,
Dimitrios Dionysopoulos
,
Flora Zagouri
,
Αngelos Koutras
,
Konstantinos Papazisis
,
Dimitrios Pectasides
,
Epaminontas Samantas
,
Meletios A Dimopoulos
,
Christos N. Papandreou
,
George Fountzilas
Article
2009
Risk of arterial cardiovascular events in patients after pulmonary embolism
Frederikus A. Klok
,
I.C.M. Mos
,
L.D. van den Broek
,
Jouke T. Tamsma
,
Frits R. Rosendaal
,
Albert de Roos
,
Menno V. Huisman
Blood
Discussion(0)
No comments yet. Be the first to comment.